This epitope was selected because it is one of the first sites to undergo phosphorylation early in AD pathogenesis.33 Following similar rationale, we produced vaccines targeting the AT8 site and PHF1 site due to their importance as disease-specific phosphorylation sites. Here, PHF1 is linked to Alzheimer disease.